Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01457014 · ClinicalTrials.gov registry record · NA

Sleep Disordered Breathing and Chronic Pain

A NA study, sponsored by Philips Respironics.

Completed
Registry status
NA
Development phase
88
Enrollment target

NCT01457014 is a NA study that has completed, run by Philips Respironics. The registered enrollment target is 88 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01457014, a NA study, has completed, sponsored by Philips Respironics.

COMPLETED
Registry status
NA
Development phase
88 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate positive pressure in patients with chronic pain taking opioid medications who have sleep disordered breathing.

Interventions

  • DEVICE Continuous positive airway pressure
  • DEVICE servo ventilation auto
  • DEVICE servo ventilation manual

Trial Details

FieldValue
Enrollment Target 88 participants
Start Date 2011-09
Est. Completion 2013-09
Phase NA

Sponsor

Philips Respironics

35 total trials

What the Registry Record Tells You About NCT01457014

The ClinicalTrials.gov registry entry for NCT01457014 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Respironics, which has 35 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Continuous positive airway pressure is the first listed.

NCT01457014 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01457014 about?

NCT01457014 is a clinical study titled "Sleep Disordered Breathing and Chronic Pain". The purpose of this study is to evaluate positive pressure in patients with chronic pain taking opioid medications who have sleep disordered breathing.

What is the current status of trial NCT01457014?

This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2011-09. Estimated completion is 2013-09.

What interventions are being tested in trial NCT01457014?

The interventions under investigation include: Continuous positive airway pressure (DEVICE), servo ventilation auto (DEVICE), servo ventilation manual (DEVICE).

Who is sponsoring clinical trial NCT01457014?

This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.